Area of research
Epidemiology · Hepatology
Research interest
Research interests include Liver Disease Diagnosis and Treatment, Liver physiology and pathology, Diet, Metabolism, and Disease, and Cardiac Fibrosis and Remodeling.
New advances in novel pharmacotherapeutic candidates for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) between 2022 and 2024
GPCRs involved in metabolic diseases: pharmacotherapeutic development updates
Hepatic progenitor cell-originated ductular reaction facilitates liver fibrosis through activation of hedgehog signaling
TREM2+ macrophages suppress CD8+ T-cell infiltration after transarterial chemoembolisation in hepatocellular carcinoma
Tyrosine kinase receptor B attenuates liver fibrosis by inhibiting TGF-β/SMAD signaling
Tunable Nanoparticles with Aggregation‐Induced Emission Heater for Precise Synergistic Photothermal and Thermodynamic Oral Cancer Therapy of Patient‐Derived Tumor Xenograft
Succinate as a signaling molecule in the mediation of liver diseases
Secretome of senescent hepatic stellate cells favors malignant transformation from nonalcoholic steatohepatitis-fibrotic progression to hepatocellular carcinoma
Alterations in gut microbiome and metabolomics in chronic hepatitis B infection-associated liver disease and their impact on peripheral immune response
Understanding initiation and progression of hepatocellular carcinoma through single cell sequencing
Updates on novel pharmacotherapeutics for the treatment of nonalcoholic steatohepatitis
Hedgehog Signaling, a Critical Pathway Governing the Development and Progression of Hepatocellular Carcinoma
Elevated Wnt2 and Wnt4 activate NF-κB signaling to promote cardiac fibrosis by cooperation of Fzd4/2 and LRP6 following myocardial infarction
Succinate‐GPR‐91 receptor signalling is responsible for nonalcoholic steatohepatitis‐associated fibrosis: Effects of DHA supplementation
<p>UBE2T promotes proliferation via G2/M checkpoint in hepatocellular carcinoma</p>
Restoration of FBP1 suppressed Snail-induced epithelial to mesenchymal transition in hepatocellular carcinoma
Reactivation of hepatitis B after liver transplantation: Current knowledge, molecular mechanisms and implications in management
JCAD Promotes Progression of Nonalcoholic Steatohepatitis to Liver Cancer by Inhibiting LATS2 Kinase Activity
Palmitic acid elicits hepatic stellate cell activation through inflammasomes and hedgehog signaling
High expression of hexokinase domain containing 1 is associated with poor prognosis and aggressive phenotype in hepatocarcinoma